RTW INVESTMENTS, LP Diversified Active

CIK: 0001493215 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value ($000): $1,386,575 (100.0% shares, 0.0% debt)

Holdings (40)

RCKT Rocket Pharmaceuticals Inc 20.9%
Value ($000) $289,448 Shares 14,969,744 Est. Cost $16.31 Unrealized +16.0%
RGNX Regenxbio Inc 10.8%
Value ($000) $149,208 Shares 2,079,555 Est. Cost $24.63 Unrealized +93.9%
PTCT Ptc Therapeutics Inc 9.9%
Value ($000) $137,406 Shares 4,073,690 Est. Cost $13.46 Unrealized +131.6%
SRPT Sarepta Therapeutics Inc 9.3%
Value ($000) $129,345 Shares 978,551 Est. Cost $74.88 Unrealized +25.9%
ARWR Arrowhead Pharmaceuticals In 8.1%
Value ($000) $112,874 Shares 8,299,542 Est. Cost $8.23 Unrealized +13.6%
Dicerna Pharmaceuticals Inc 4.5%
Value ($000) $61,799 Shares 5,044,813 Est. Cost $10.56 Unrealized
BMY Bristol Myers Squibb Co 3.6%
Value ($000) $50,009 Shares 903,672 Est. Cost $43.52 Unrealized -6.6%
LIVN Livanova PLC 3.1%
Value ($000) $43,022 Shares 431,000 Est. Cost $88.96 Unrealized +2.0%
La Jolla Pharmaceutical Co 2.8%
Value ($000) $39,259 Shares 1,345,881 Est. Cost $26.28 Unrealized
Achillion Pharmaceuticals In 2.8%
Value ($000) $38,324 Shares 13,541,997 Est. Cost $3.82 Unrealized
ABUS Arbutus Biopharma Corp 2.7%
Value ($000) $37,708 Shares 5,165,499 Est. Cost $3.27 Unrealized +82.2%
ALNY Alnylam Pharmaceuticals Inc 2.5%
Value ($000) $34,688 Shares 352,200 Est. Cost $82.31 Unrealized +20.5%
MASI Masimo Corp 1.8%
Value ($000) $24,368 Shares 249,543 Est. Cost $77.72 Unrealized +22.3%
Solid Biosciences Inc 1.6%
Value ($000) $22,753 Shares 675,771 Est. Cost $6.82 Unrealized
VCEL Vericel Corp 1.6%
Value ($000) $21,514 Shares 2,217,916 Est. Cost $6.40 Unrealized +94.6%
Agenus Inc 1.5%
Value ($000) $21,282 Shares 9,375,451 Est. Cost $6.00 Unrealized
Qiagen NV 1.4%
Value ($000) $19,143 Shares 529,385 Est. Cost $36.16 Unrealized
QURE Uniqure NV 1.1%
Value ($000) $15,474 Shares 409,370 Est. Cost $15.23 Unrealized +110.3%
Corium Intl Inc 1.1%
Value ($000) $15,405 Shares 1,923,217 Est. Cost $8.35 Unrealized
ILMN Illumina Inc 1.0%
Value ($000) $13,869 Shares 49,658 Est. Cost $254.40 Unrealized 0.0%
Myokardia Inc 0.9%
Value ($000) $12,978 Shares 261,395 Est. Cost $42.84 Unrealized
VRAYQ Viewray Inc 0.7%
Value ($000) $10,201 Shares 1,474,156 Est. Cost $6.41 Unrealized +13.3%
Polarityte Inc 0.7%
Value ($000) $10,044 Shares 426,670 Est. Cost $23.54 Unrealized
CDNA Caredx Inc 0.7%
Value ($000) $9,358 Shares 764,532 Est. Cost $7.58 Unrealized +51.3%
Bovie Medical Corp 0.7%
Value ($000) $9,057 Shares 2,082,137 Est. Cost $3.19 Unrealized
Electrocore Inc 0.6%
Value ($000) $8,338 Shares 505,000 Est. Cost $16.51 Unrealized
Nuvectra Corp 0.6%
Value ($000) $7,864 Shares 383,030 Est. Cost $13.02 Unrealized
Viveve Med Inc 0.6%
Value ($000) $7,782 Shares 2,861,023 Est. Cost $4.34 Unrealized
Odonate Therapeutics Inc 0.4%
Value ($000) $6,102 Shares 276,368 Est. Cost $22.75 Unrealized
STIM Neuronetics Inc 0.4%
Value ($000) $5,056 Shares 190,000 Est. Cost $27.20 Unrealized 0.0%
Homology Medicines Inc 0.3%
Value ($000) $4,619 Shares 226,431 Est. Cost $18.70 Unrealized
Novavax Inc 0.3%
Value ($000) $3,543 Shares 2,644,346 Est. Cost $2.10 Unrealized
Vivus Inc 4.5 05/01/2020 0.2%
Value ($000) $3,140 Shares 4,000,000 Est. Cost $0.79 Unrealized
Proteostasis Therapeutics In 0.2%
Value ($000) $3,006 Shares 1,077,408 Est. Cost $5.83 Unrealized
ARGX Argenx Se 0.2%
Value ($000) $2,118 Shares 25,559 Est. Cost $21.81 Unrealized
Novus Therapeutics Inc 0.2%
Value ($000) $2,113 Shares 301,799 Est. Cost $5.04 Unrealized
Tapimmune Inc 0.1%
Value ($000) $1,886 Shares 200,000 Est. Cost $9.43 Unrealized
Bellicum Pharmaceuticals Inc 0.1%
Value ($000) $1,109 Shares 150,289 Est. Cost $7.38 Unrealized
Adverum Biotechnologies Inc 0.1%
Value ($000) $935 Shares 176,372 Est. Cost $5.80 Unrealized
Motus Gi Hldgs Inc 0.0%
Value ($000) $428 Shares 59,478 Est. Cost $4.48 Unrealized